Anti-Mullerian Hormone Levels Before and After an Open Myomectomy

Clinique Ovo21 enrolled

Overview

Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. It is well known that ovarian surgery for endometriosis lowers Anti-Mullerian hormone, but little is known for other surgeries. We seek to investigate the hormone variations before and after an open myomectomy. Hypothesis: Anti-Mullerian hormone levels drop following surgery but return to normal levels in a few months

Study Type

OBSERVATIONAL

Enrollment

Conditions

Anti-Mullerian Hormone

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 42 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 to 42 years old * Requiring open myomectomy for any indication Exclusion Criteria: * Incapable of informed consent * Use of hormonal contraception or Gonadotropin-releasing hormone agonists in the past 3 months * Woman over 42 years old * Post-menopause women * Positive B-human chorionic gonadotropin the day of surgery * Ovarian surgery (at the same time) * Pre-operative AMH below 0.3 ng/mL

Locations (1)

Hopital Saint-Luc

Montreal, Quebec, Canada

Outcomes

Primary Outcomes

Anti-Mullerian Hormone levels variation

Anti-Mullerian Hormone levels before and 6 months after surgery

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.